St. Jude Medical won FDA clearance for its EnSite Precision cardiac mapping system and the Advisor FL Circular Mapping Catheter, Sensor Enabled. The electrophysiology system is intended to help identify ablation targets in patients with cardiac arrhythmias, including atrial fibrillation or ventricular tachycardia. It can be used with any electrophysiology catheters, and built-in tools help reduce radiation exposure by relying less on fluoroscopy.
The EnSite Precision is based on the popular EnSite Velocity system, and now offers features such as EnSite AutoMap Module for helping to correlate the source of the electrical signals with the physical anatomy of the heart. Additionally, the same module has a so-called TurboMap capability for quickly creating a map of the heart from recorded data.
The company believes that clinicians should expect shorter mapping times and therefore faster completion of cardiac ablation procedures.
The system has been CE Marked in Europe since January of 2016.
Via: St. Jude Medical…